Study limitations include the single-center and retrospective design, provision of Paxlovid to low-risk individuals, reliance on pharmacy records, and small cohort size. “Larger pediatric studies are ...

A large-scale study reveals azvudine’s comparable efficacy to Paxlovid, fewer adverse effects, and potential antitumor benefits in patients with liver cancer. Study: Real‐world effectiveness ...

A recent study from the University of California, San Francisco, offers a closer look at how some patients respond to extended courses of Paxlovid, a combination of nirmatrelvir and ritonavir.

Some long COVID patients who took an extended course of Paxlovid saw temporary or lasting improvement, according to a small new case series published in the journal Communications Medicine. A previous ...